What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Supply Chain Series | Distribution: 340B Solutions, Management Systems | Quarter 4

The Pharmacy Outlook 2026 report is now available

Accelerate Pharmacy Solutions surveyed more than 100 health system pharmacy leaders to understand the challenges and opportunities driving pharmacy in 2026. The result is a report designed to help you benchmark your program, prioritize what’s next, and make the case for investment.

What we found:

  • Half of specialty patients still fill externally, driven by payer restrictions and affordability barriers.
  • 340B optimization is the #1 financial priority for 2026, even as manufacturer restrictions and compliance pressures increase.
  • Nearly one in three health systems plan to launch a home infusion program in the next three years.

See the findings shaping pharmacy and inform your 2026 planning here >

Supply Chain Series: Investing in a More Resilient and Efficient Supply Chain

Move pharmacy forward and accelerate 340B program success with innovative technology driven by industry-leading experts.

Watch Video >

Cencora

Cencora News & Announcements

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Supply Chain Series | Distribution: 340B Solutions, Management Systems | Quarter 4

Name
Address
Subscribe